by Protea Foundation | Mar 14, 2024 | Uncategorized
MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial Results from the phase 3 placebo-controlled MAPP2 trial show that MDMA-assisted therapy reduces post-traumatic stress disorder (PTSD) symptoms and functional impairment...
